Is ImpediMed Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, ImpediMed Ltd (IPD.AX) is currently classified as NOT HALAL as of April 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is ImpediMed Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ImpediMed Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of ImpediMed Ltd?

Muslim investors may consider investing in ImpediMed Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is ImpediMed Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of ImpediMed Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for ImpediMed Ltd updated?

The Shariah compliance status of ImpediMed Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like ImpediMed Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of ImpediMed Ltd?

You can check the latest Shariah compliance status of ImpediMed Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IPD.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 16, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for ImpediMed Ltd (IPD.AX)

Based on 8 analysts giving stock ratings to ImpediMed Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

ImpediMed Ltd. Stock Analysis IPD.AX

Australia Health Care Nano Cap Report: Q2, 2025

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 77 full-time employees. The company went IPO on 2007-10-24. The firm uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The firm designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.

Key Statistics of ImpediMed Ltd (IPD.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.01AUD0.01

Today's Open

AUD0.01

Volume

2.64M

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.06

Market Cap

18.35M

Avg. Volume

674.53K

Dividend Yield

Financial Metrics & Statements of ImpediMed Ltd (IPD.AX)

FAQ's for ImpediMed Ltd (IPD.AX)

According to Musaffa’s Shariah screening methodology, ImpediMed Ltd (IPD.AX) is currently classified as NOT HALAL as of April 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.